In this study, we systematically screened for rare variants and pathogenic mutations in the SNCA, LRRK2, PARK2, PINK1, PARK7, MAPT and GBA genes in a series of well-characterized PD case-control samples. This evidence concerns the gene LRRK2 and Parkinson disease.